PROTEIN DEGRADATION-
UBIQUITIN PATHWAY
By
KAVIYA PRIYAA
(23PBT007)
II MSc Biotechnology
PROTEIN DEGRADATION
 Protein degradation is the process by which proteins are
naturally destroyed in a cell in order to maintain protein
homeostasis, or an equilibrium of proteins in the human
body.
 The body is constantly making and remaking proteins
(creation), while also removing ones that have become
inactive or mutated (degradation).
 When a cell is unable to degrade certain proteins, the
proteins can accumulate, causing diseases like cancer.
 The end product of protein degradation is amino acids.
TYPES OF PROTEIN DEGRADATION
 Proteasomal pathway
In general, proteasomes eliminate short-lived proteins and
soluble misfolded proteins by the ubiquitin–proteasome
system.
 Lysosomal Pathways
In contrast, lysosomes are responsible for degradation of
long-lived proteins, insoluble protein aggregates and
intracellular parasites (e.g. certain bacteria) via
endocytosis, phagocytosis, or autophagy pathways.
LYSOSOMAL PATHWAYS
Protein degradation via three distinct lysosome pathways.
 Cell surface proteins arrive at endosome after endocytosis. They
could be degraded by lysosome, or transported to the plasma
membrane or other cellular organelles for recycling.
 In the phagocytic pathway, cells engulf large extracellular
particles, such as invading pathogens and dead cells, and then
degrade them by lysosome.
 Misfolded or aggregated proteins, damaged organelles, and
intracellular pathogens, are removed by the autophagy–lysosome
pathway.
There are three different forms of autophagy:
1. Macro autophagy
2. Micro autophagy
3. Chaperone-mediated autophagy.
Lysosomes:
• A lysosome is a membrane-bound cell organelle that
contains digestive enzymes.
• The digestive enzymes that require this acid, low-pH
environment. Those enzymes are called hydrolytic
enzymes.
UBIQUITINATION PATHWAY
 The addition of ubiquitin to a substrate protein is
called ubiquitylation (or, alternatively, ubiquitination or
ubiquitinylation).
 Ubiquitylation affects proteins in many ways: it can mark them
for degradation via the proteasome.
UBIQUITIN
 Ubiquitin is a small regulatory protein found in most tissues of
eukaryotic organisms.
 Include its C-terminal tail and the 7 lysine residues.
 It is highly conserved throughout eukaryote evolution.
STRUCTURE OF UBIQUITIN
PROTEOSOME
 Proteasomes are complex
intracellular proteases that
function in regulated
degradation of cellular
proteins
 Proteasomes of
eukaryotes are two types,
the 20S and 26S
proteasomes.
ENZYMES INVOLVED IN
UBIQUITINATION
1.Ubiquitin-activating enzymes (E1S)
Carboxyl end of ubiquitin is linked to the E1 enzyme through bond
with the help of ATP .
2.Ubiquitin -conjugating enzymes (E2s)
Activated ubiquitin is transfer to residue of E2
3.Ubiquitin ligases (E3s)
Transfer the ubiquitin to the targeted proteins.
4.Deubiquitinating enzymes (DUBs)
Destructions of isopeptide bond and the removal of monoubiqutin and
polyubiquitin chains from proteins.
MECHANISM OF UBIQUITIN PATHWAY
 Ubiquitin modification is an ATP-dependent process carried out
by three classes of enzymes.
ACTIVATION
 “ubiquitin activating enzyme” (E1) forms a thio-ester bond
with ubiquitin, a highly conserved 76-amino acid protein.
CONJUGATION
 This reaction allows subsequent binding of ubiquitin to a
“ubiquitin conjugating enzyme” (E2), followed by the formation
of an isopeptide bond between the carboxyl-terminus of
ubiquitin and a lysine residue on the substrate protein.
LIGATION
The latter reaction requires a “ubiquitin ligase” (E3)
1. Synthesis of protein substrate-anchored polyubiquitin
chain.
2. Degradation of the polyubiquitin-conjugated substrate
by the proteasome.
APPLICATION
1. Preventing formation of Cancer cells.
2. Maintains homeostasis of cell.
3. Regulates equilibrium of cells.
4. Protac-induced Protein degradation in drug
discovery.
5. Targeted protein degradation using intracellular
Antibodies for neurodegenerative disease
THANK YOU
https://youtu.be/jbc1QCu9hFg?si=NQdNFK4AA1OkgzfA

PROTEIN DEGRADATION via ubiquitous pathaway

  • 1.
    PROTEIN DEGRADATION- UBIQUITIN PATHWAY By KAVIYAPRIYAA (23PBT007) II MSc Biotechnology
  • 2.
    PROTEIN DEGRADATION  Proteindegradation is the process by which proteins are naturally destroyed in a cell in order to maintain protein homeostasis, or an equilibrium of proteins in the human body.  The body is constantly making and remaking proteins (creation), while also removing ones that have become inactive or mutated (degradation).  When a cell is unable to degrade certain proteins, the proteins can accumulate, causing diseases like cancer.  The end product of protein degradation is amino acids.
  • 3.
    TYPES OF PROTEINDEGRADATION  Proteasomal pathway In general, proteasomes eliminate short-lived proteins and soluble misfolded proteins by the ubiquitin–proteasome system.  Lysosomal Pathways In contrast, lysosomes are responsible for degradation of long-lived proteins, insoluble protein aggregates and intracellular parasites (e.g. certain bacteria) via endocytosis, phagocytosis, or autophagy pathways.
  • 4.
    LYSOSOMAL PATHWAYS Protein degradationvia three distinct lysosome pathways.  Cell surface proteins arrive at endosome after endocytosis. They could be degraded by lysosome, or transported to the plasma membrane or other cellular organelles for recycling.  In the phagocytic pathway, cells engulf large extracellular particles, such as invading pathogens and dead cells, and then degrade them by lysosome.  Misfolded or aggregated proteins, damaged organelles, and intracellular pathogens, are removed by the autophagy–lysosome pathway.
  • 5.
    There are threedifferent forms of autophagy: 1. Macro autophagy 2. Micro autophagy 3. Chaperone-mediated autophagy. Lysosomes: • A lysosome is a membrane-bound cell organelle that contains digestive enzymes. • The digestive enzymes that require this acid, low-pH environment. Those enzymes are called hydrolytic enzymes.
  • 7.
    UBIQUITINATION PATHWAY  Theaddition of ubiquitin to a substrate protein is called ubiquitylation (or, alternatively, ubiquitination or ubiquitinylation).  Ubiquitylation affects proteins in many ways: it can mark them for degradation via the proteasome. UBIQUITIN  Ubiquitin is a small regulatory protein found in most tissues of eukaryotic organisms.  Include its C-terminal tail and the 7 lysine residues.  It is highly conserved throughout eukaryote evolution.
  • 8.
  • 9.
    PROTEOSOME  Proteasomes arecomplex intracellular proteases that function in regulated degradation of cellular proteins  Proteasomes of eukaryotes are two types, the 20S and 26S proteasomes.
  • 11.
    ENZYMES INVOLVED IN UBIQUITINATION 1.Ubiquitin-activatingenzymes (E1S) Carboxyl end of ubiquitin is linked to the E1 enzyme through bond with the help of ATP . 2.Ubiquitin -conjugating enzymes (E2s) Activated ubiquitin is transfer to residue of E2 3.Ubiquitin ligases (E3s) Transfer the ubiquitin to the targeted proteins. 4.Deubiquitinating enzymes (DUBs) Destructions of isopeptide bond and the removal of monoubiqutin and polyubiquitin chains from proteins.
  • 12.
    MECHANISM OF UBIQUITINPATHWAY  Ubiquitin modification is an ATP-dependent process carried out by three classes of enzymes. ACTIVATION  “ubiquitin activating enzyme” (E1) forms a thio-ester bond with ubiquitin, a highly conserved 76-amino acid protein. CONJUGATION  This reaction allows subsequent binding of ubiquitin to a “ubiquitin conjugating enzyme” (E2), followed by the formation of an isopeptide bond between the carboxyl-terminus of ubiquitin and a lysine residue on the substrate protein.
  • 13.
    LIGATION The latter reactionrequires a “ubiquitin ligase” (E3) 1. Synthesis of protein substrate-anchored polyubiquitin chain. 2. Degradation of the polyubiquitin-conjugated substrate by the proteasome.
  • 15.
    APPLICATION 1. Preventing formationof Cancer cells. 2. Maintains homeostasis of cell. 3. Regulates equilibrium of cells. 4. Protac-induced Protein degradation in drug discovery. 5. Targeted protein degradation using intracellular Antibodies for neurodegenerative disease
  • 16.